These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30905295)

  • 1. Editing the microbiome the CRISPR way.
    Ramachandran G; Bikard D
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180103. PubMed ID: 30905295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome.
    Nath A; Bhattacharjee R; Nandi A; Sinha A; Kar S; Manoharan N; Mitra S; Mojumdar A; Panda PK; Patro S; Dutt A; Ahuja R; Verma SK; Suar M
    Biomed Pharmacother; 2022 Jul; 151():113122. PubMed ID: 35594718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas systems in oral microbiome: From immune defense to physiological regulation.
    Gong T; Zeng J; Tang B; Zhou X; Li Y
    Mol Oral Microbiol; 2020 Apr; 35(2):41-48. PubMed ID: 31995666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the CRISPR-Based Therapeutics.
    Li B; Niu Y; Ji W; Dong Y
    Trends Pharmacol Sci; 2020 Jan; 41(1):55-65. PubMed ID: 31862124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
    Bradde S; Mora T; Walczak AM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CRISPR-Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives.
    Nidhi S; Anand U; Oleksak P; Tripathi P; Lal JA; Thomas G; Kuca K; Tripathi V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 13. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
    Newsom S; Parameshwaran HP; Martin L; Rajan R
    Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas Technologies and Applications in Food Bacteria.
    Stout E; Klaenhammer T; Barrangou R
    Annu Rev Food Sci Technol; 2017 Feb; 8():413-437. PubMed ID: 28245154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
    Nayeemul Bari SM; Hatoum-Aslan A
    Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.